172 related articles for article (PubMed ID: 8049882)
1. Pharmacological control of gastric acid secretion.
Zfass AM; McHenry L; Sanyal AJ
Gastroenterologist; 1993 Mar; 1(1):83-7. PubMed ID: 8049882
[TBL] [Abstract][Full Text] [Related]
2. Impact of acid-related disorders in the United States.
Brown M; Yang RD
Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole: a comprehensive review.
Massoomi F; Savage J; Destache CJ
Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
[TBL] [Abstract][Full Text] [Related]
4. Control of gastric acid secretion in health and disease.
Schubert ML; Peura DA
Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of acid-suppressive agents in patients with gastroesophageal reflux disease.
Schentag JJ; Goss TF
Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S7-10. PubMed ID: 8097364
[TBL] [Abstract][Full Text] [Related]
6. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the pharmacology of acid control in acid-related disorders.
Howden CW
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):17S-19S; discussion 19S-21S. PubMed ID: 9127622
[TBL] [Abstract][Full Text] [Related]
8. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
9. Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease.
Collen MJ; Abdulian JD; Chen YK
Am J Gastroenterol; 1994 May; 89(5):712-6. PubMed ID: 8172143
[TBL] [Abstract][Full Text] [Related]
10. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Bown RL
Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
[TBL] [Abstract][Full Text] [Related]
11. Optimizing acid suppression for treatment of acid-related diseases.
Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
Garnett WR
Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
[TBL] [Abstract][Full Text] [Related]
13. [Preparation sanpraz (pantoprazole): experience of application in treatment of gastroesophageal reflux disease and other acid related diseases].
Sharova EP
Eksp Klin Gastroenterol; 2008; (6):74-6. PubMed ID: 19334429
[No Abstract] [Full Text] [Related]
14. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
16. Appropriate acid suppression in the treatment of acid-related conditions.
Howden CW
Pharmacol Ther; 1994; 63(1):123-34. PubMed ID: 7972343
[TBL] [Abstract][Full Text] [Related]
17. Cell physiology and pharmacology of gastric acid secretion.
Lewin MJ
Therapie; 1992; 47(2):93-6. PubMed ID: 1357771
[TBL] [Abstract][Full Text] [Related]
18. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
Kawai T; Yagi K; Moriyasu F
Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer.
Corinaldesi R; Stanghellini V; Borghi C; Casadio R; Miglioli M; Bugiardini R; Barbara L
Hepatogastroenterology; 1984 Apr; 31(2):88-90. PubMed ID: 6233212
[TBL] [Abstract][Full Text] [Related]
20. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
Gabryelewicz A; Sarosiek J; Laszewicz W
Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
